Skip to content
All news
General

Intel Stock Hits Fourth Straight Record High on Apple Chip Deal Report

Intel (INTC) shares hit a fourth straight record high following reports of a preliminary chip-making agreement with Apple (AAPL). The potential deal boosts Intel's foundry ambitions and lifts the broader semiconductor sector.

May 8, 2026
2 min read
Source: Yahoo Finance
Share:

Intel (INTC) shares surged to a new all-time high for the fourth consecutive session, driven by reports that the company has reached a preliminary chip-making agreement with Apple (AAPL). This development fuels investor optimism about Intel's turnaround as a major player in the semiconductor foundry market.

Details of the Potential Deal

According to media reports, Intel and Apple have reached a preliminary agreement for Intel to manufacture some of Apple's chips. Financial terms and timelines have not been disclosed, but the deal marks a significant step for Intel in attracting high-profile clients.

Context

The news comes as Intel seeks to diversify its business by offering foundry services to competitors like Apple, which currently relies on TSMC. The potential deal follows a series of challenges Intel has faced in recent years, including manufacturing delays.

Market Impact

Intel's stock has risen sharply over the past four sessions, pushing its market capitalization to record levels. Other semiconductor stocks such as AMD and Broadcom also saw modest gains, but the focus remains on Intel.

What This Means for Investors

If finalized, the deal could significantly boost Intel's revenue and solidify its position in the foundry market. However, investors should watch for final details and potential regulatory approvals.

Frequently Asked Questions

Intel's stock rose due to reports of a preliminary chip-making agreement with Apple, boosting investor hopes for Intel's foundry business.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.